SAB Biotherapeutics, Inc. Warrant (SABSW)

EARNINGS ANALYTICS
search

Earnings reactions

How SABSW moved on each past earnings report.

Up Down

Earnings Impact

SAB Biotherapeutics, Inc. Warrant (SABSW) is a warrant and does not report quarterly earnings, so there is no earnings-reaction history to display.

Historical Earnings Statistics

SAB Biotherapeutics, Inc. Warrant (SABSW) is a warrant and does not report quarterly earnings, so there is no earnings-reaction history to display.

event

Earnings Count

0

Total earnings in dataset

trending_up

Avg Abs. Movement

±0.00%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 16 →
16
Funds holding
$21192908
Total value held
Buying
14 added · 2 reduced
Blackrock, Inc.
$11957462 +917.51%
Ameriprise Financial Inc
$2382975 NEW BUY
State Street Corp
$2070241 +615.11%
Ubs Group Ag
$1427009 NEW BUY
Northern Trust Corp
$1413707 +531.23%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
424B3 20260821 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G 20260812 open_in_new SEC.gov
SCHEDULE 13D/A 20260810 open_in_new SEC.gov
10-Q 20260806 open_in_new SEC.gov